Nicotinic Acid to Nicotinamide Ratio, a Marker for Assessing Broad-based Bacterial Contamination in Cell Therapy Products
The present invention relates to a method of detecting the presence of a bacteria and/or fungal cell in a sample through detecting the presence of a nicotinamidase activity or nicotinamidase, wherein the presence of nicotinamidase activity of nicotinamidase indicates the presence of a bacteria and/or fungal cell in the sample. The invention also relates to a method for monitoring bacterial and/or fungal cell contamination in a cell of tissue culture comprising detecting the presence of nicotinamidase activity or nicotinamidase in the cell or tissue culture.
Researchers
-
method of detecting bacterial/fungal contamination
European Patent Convention | Published application -
method of detecting bacterial/fungal contamination in a therapeutic product
Singapore | Pending -
method of detecting bacterial/fungal contamination
United States of America | Published application
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.